RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
RocketVax has raised $4.4M in total funding. The most recent round was Seed. The last funding was announced in August 2021.
RocketVax's investors include Innosuisse, University Hospital Basel, Canton of Basel-Stadt.
RocketVax is headquartered in Basel, Switzerland.
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
RocketVax is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RocketVax — Funding & Investors." VCBacked, August 3, 2021, https://www.vcbacked.co/company/rocketvax. Accessed August 15, 2026.
VCBacked. (2021). RocketVax — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/rocketvax
{{cite web |title=RocketVax — Funding & Investors |url=https://www.vcbacked.co/company/rocketvax |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated